An interventional study of Warfarin Telehealth Education in Educational Problems and Medication Adherence, sponsored by Baylor Research Institute. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-15.
Sponsored by Baylor Research Institute · Not applicable, Interventional, and Other
The objective of this study is to evaluate the effectiveness of telehealth warfarin education in a charity outpatient clinic. The purpose is to increase patient knowledge with regard to their warfarin therapy and to measure knowledge retention
2. This study is conducted in outpatient ambulatory care clinics at the Baylor Family Medicine Worth Street clinic and the Irving Interfaith clinic. The average census for warfarin patients Friday clinic is 10. The anticoagulation clinic consists of an interdisciplinary team including physicians, medical assistants, nurse practitioners, and pharmacists. Patients initially visit with the provider and subsequent follow up INR checks are performed by the pharmacists or medical assistants. Currently, pharmacists manage the anticoagulation clinic on Fridays and medical assistants manage the clinic on Monday through Thursday. All providers provide patient education through written brochures.
3. Study Design
a. This study is a prospective, single-centered, randomized controlled quality improvement pilot study.
4. Warfarin Education Procedures
Intervention patients (iPAD® video)
5. Description of iPAD video
a. Setting: a pharmacy b. Description: A pharmacist will provide education about warfarin using not only verbal instructions but also provide illustrations of directions. Please refer to Appendix for dialogue.
6. Control group
a. Patients' INR will be taken and warfarin education will be given verbally similar to Monday-Thursday clinic. A written brochure will be given.
240 studies on the registry are indexed under Medication Adherence; 111 are open to participants now.
This study's enrollment of 18 is below the median of 120 across 203 interventional studies indexed under Medication Adherence.
Browse Medication Adherence studies →Baylor Research Institute is the lead sponsor of 223 studies on the registry; 49 are open to participants now.
Of its 23 completed or terminated interventional studies of FDA-regulated products, 9 (39%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients received education on warfarin through a video on an iPad, and were assessed on knowledge pre and post video, and at follow up visit
Knowledge Retention of Warfarin Education post video watching
Difference in pre warfarin education video and post video test for warfarin education in patients receiving warfarin education via iPad
Time frame: pre and post video test(20 minutes)
Long Term Knowledge Retention of warfarin education post video watching
Difference in pre video test and follow up retention test for warfarin education in patients receiving warfarin education via iPad
Time frame: initial and follow up visit (max 30 days)
Self Reported Adherence to Warfarin therapy during duration of study
Descriptive results of patient self reported adherence (yes/no response) related to warfarin between initial and follow up visit
Time frame: Between initial and follow up visit ( max 30 days)
Satisfaction Survey
A satisfaction survey (designed by pharmacy resident) with 4 questions based on Likert scale (0-5), and one free response question patient completes on follow up visit. Name of Scale used for 4 questions: Likert. (Range 1-5, 1= highly disagree, 2= disagree, 3-neutral, 4-agree, 5-highly agree). There was no total of scoring, each response was individual of each other.
Time frame: Max 30 days
Adverse Events
Descriptive results of patient self reported adverse events related to warfarin between initial and follow up visit
Time frame: Between initial and follow up visit ( max 30 days)
Time of Warfarin in Therapeutic Range for Duration of Study
Time patient was within therapeutic range for their INR goal between initial and follow up visit
Time frame: Between initial and follow up visit ( max 30 days)
No study locations are listed for this record.
Plan to share: Undecided
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.